BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24247930)

  • 1. Microarray profiling of human renal cell carcinoma: identification for potential biomarkers and critical pathways.
    Li W; Zhu W; Che J; Sun W; Liu M; Peng B; Zheng J
    Kidney Blood Press Res; 2013; 37(4-5):506-13. PubMed ID: 24247930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of feature genes of the renal cell carcinoma with DNA microarray.
    Feng JY; Diao XW; Fan MQ; Wang PX; Xiao Y; Zhong X; Wu RH; Huang CB
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(22):2994-3001. PubMed ID: 24302177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the microRNA-target gene regulatory network in renal cell carcinomas, identification for potential biomarkers and critical pathways.
    Li J; Huang JH; Qu QH; Xia Q; Wang DS; Jin L; Sheng C
    Int J Clin Exp Med; 2015; 8(5):7209-19. PubMed ID: 26221260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of the estrogen receptor target genes in renal cell carcinoma.
    Liu Z; Lu Y; He Z; Chen L; Lu Y
    Mol Med Rep; 2015 Jan; 11(1):75-82. PubMed ID: 25351113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of key genes and pathways in renal cell carcinoma through expression profiling data.
    Liu X; Wang J; Sun G
    Kidney Blood Press Res; 2015; 40(3):288-97. PubMed ID: 26043775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identified differently expressed genes in renal cell carcinoma by using multiple microarray datasets running head: differently expressed genes in renal cell carcinoma.
    Cheng Y; Hong M; Cheng B
    Eur Rev Med Pharmacol Sci; 2014; 18(7):1033-40. PubMed ID: 24763884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening candidate genes associated with bladder cancer using DNA microarray.
    Xu A; Wang C; Sun S
    Mol Med Rep; 2014 Dec; 10(6):3087-91. PubMed ID: 25323786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revealing the underlying mechanism of diabetic nephropathy viewed by microarray analysis.
    Qu W; Han C; Li M; Zhang J; Li L
    Exp Clin Endocrinol Diabetes; 2015 Jun; 123(6):353-9. PubMed ID: 25918880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential biomarkers and latent pathways for vasculitis based on latent pathway identification analysis.
    Zhou T; Zhang Y; Wu P; Sun Q; Guo Y; Yang Y
    Int J Rheum Dis; 2014 Jul; 17(6):671-8. PubMed ID: 24867262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIR-142-5p and miR-9 may be involved in squamous lung cancer by regulating cell cycle related genes.
    Su YH; Zhou Z; Yang KP; Wang XG; Zhu Y; Fa XE
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(23):3213-20. PubMed ID: 24338464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma.
    Wu F; Wu S; Gou X
    Neoplasma; 2018; 65(2):242-252. PubMed ID: 29534586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
    Wang S; Yu ZH; Chai KQ
    Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate target genes of pituitary adenomas based on the DNA microarray.
    Zhou W; Ma CX; Xing YZ; Yan ZY
    Mol Med Rep; 2016 Mar; 13(3):2182-6. PubMed ID: 26782791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network spatio-temporal analysis predicts disease stage-related genes and pathways in renal cell carcinoma.
    Li1 XH; Yang CZ; Wang J
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome network analysis reveals candidate genes for renal cell carcinoma.
    Zhai W; Xu YF; Liu M; Zheng JH
    J Cancer Res Ther; 2012; 8(1):28-33. PubMed ID: 22531510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-protein interaction network analysis of children atopic asthma.
    Liu Y; Liu S
    Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):867-72. PubMed ID: 22953633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of differentially expressed genes in ductal carcinoma with DNA microarray.
    Zhang BH; Liu J; Zhou QX; Zuo D; Wang Y
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(6):758-66. PubMed ID: 23609359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.